The Trump administration plans to ensure transparency and accuracy in drug ads, including by increasing the amount of information related to any product risks.

The Trump administration plans to ensure transparency and accuracy in drug ads, including by increasing the amount of information related to any product risks.

The administration is proposing a return to a 1990s-era policy that kept most drug ads off TV. That could dent the revenues of drugmakers and major networks.